Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Accuray Incorporated stock (ARAY)

Buy Accuray Incorporated stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Accuray Incorporated is a medical devices business based in the US. Accuray Incorporated shares (ARAY) are listed on the NASDAQ and all prices are listed in US Dollars. Accuray Incorporated employs 1,024 staff and has a trailing 12-month revenue of around $430.6 million.

Our top picks for where to buy Accuray Incorporated stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Accuray Incorporated stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ARAY. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Accuray Incorporated stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
OPTO
Not rated yet
OPTO
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
★★★★★
Stocks, ETFs, Cryptocurrency
$0
$0
4.5%
N/A
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Accuray Incorporated stock price (NASDAQ: ARAY)

Use our graph to track the performance of ARAY stocks over time.

Accuray Incorporated shares at a glance

Information last updated 2024-07-14.
Latest market close$1.95
52-week range$1.46 - $4.30
50-day moving average $1.72
200-day moving average $2.41
Wall St. target price$6.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.22

Is it a good time to buy Accuray Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Accuray Incorporated price performance over time

Historical closes compared with the close of $1.95 from 2024-07-17

1 week (2024-07-12) -1.02%
1 month (2024-06-18) 12.07%
3 months (2024-04-19) -8.88%
6 months (2024-01-19) -29.86%
1 year (2023-07-19) -50.00%
2 years (2022-07-19) -7.14%
3 years (2021-07-19) 3.91
5 years (2019-07-19) 3.98

Is Accuray Incorporated stock undervalued or overvalued?

Valuing Accuray Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Accuray Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Accuray Incorporated's PEG ratio

Accuray Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.08. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Accuray Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Accuray Incorporated's EBITDA

Accuray Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 million.

The EBITDA is a measure of a Accuray Incorporated's overall financial performance and is widely used to measure a its profitability.

Accuray Incorporated financials

Revenue TTM $430.6 million
Operating margin TTM 3.73%
Gross profit TTM $154 million
Return on assets TTM -0.56%
Return on equity TTM -44.87%
Profit margin -4.99%
Book value $0.41
Market Capitalization $195.5 million

TTM: trailing 12 months

Accuray Incorporated share dividends

We're not expecting Accuray Incorporated to pay a dividend over the next 12 months.

Accuray Incorporated share price volatility

Over the last 12 months, Accuray Incorporated's shares have ranged in value from as little as $1.4641 up to $4.299. A popular way to gauge a stock's volatility is its "beta".

ARAY.US volatility(beta: 1.46)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accuray Incorporated's is 1.455. This would suggest that Accuray Incorporated's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Accuray Incorporated overview

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin. .

Frequently asked questions

null
What percentage of Accuray Incorporated is owned by insiders or institutions?
Currently 3.533% of Accuray Incorporated shares are held by insiders and 64.893% by institutions.
How many people work for Accuray Incorporated?
Latest data suggests 1,024 work at Accuray Incorporated.
When does the fiscal year end for Accuray Incorporated?
Accuray Incorporated's fiscal year ends in June.
Where is Accuray Incorporated based?
Accuray Incorporated's address is: 1240 Deming Way, Madison, WI, United States, 53717-1954
What is Accuray Incorporated's ISIN number?
Accuray Incorporated's international securities identification number is: US0043971052
What is Accuray Incorporated's CUSIP number?
Accuray Incorporated's Committee on Uniform Securities Identification Procedures number is: 004397105

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site